Funding for this research was provided by:
Center for Research on Coronaviruses and Other Emerging Pathogens
Received: 6 October 2020
Accepted: 24 May 2021
First Online: 3 June 2021
: All sample collection was carried out under IRB-approved protocols (IRB protocol #842613 and #813913) and complied with the Helsinki Declaration. Salivary samples were collected from possible SARS-CoV-2-positive patients at one of three locations: (1) Penn Presbyterian Medical Center Emergency Department, (2) Hospital of the University of Pennsylvania Emergency Department, and (3) Penn Medicine COVID-19 ambulatory testing center. Inclusion criteria including any adult (age>17 years) who underwent SARS-CoV-2 testing via standard nasopharyngeal swab at the same visit. Patients with known COVID-19 disease who tested positive previously were excluded. After verbal consent was obtained by a trained research coordinator, patients were instructed to self-collect the saliva into a sterile specimen container which was then placed on ice until further processing for analysis.
: All authors have reviewed the manuscript and consented to allow publication.
: The authors declare that they have no competing interests.